1d2q › Citations

2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity.

Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC, Sung YC, Oh BH
Immunity 11 253-61 (1999)
Cited: 93 times
EuropePMC logo PMID: 10485660

Abstract

TRAIL is a newly identified cytokine belonging to the large tumor necrosis factor (TNF) family. TRAIL is a novel molecule inducing apoptosis in a wide variety of tumor cells but not in normal cells. To help in elucidating its biological roles and designing mutants with improved therapeutic potential, we have determined the crystal structure of human TRAIL. The structure reveals that a unique frame insertion of 12-16 amino acids adopts a salient loop structure penetrating into the receptor-binding site. The loop drastically alters the common receptor-binding surface of the TNF family most likely for the specific recognition of cognate partners. A structure-based mutagenesis study demonstrates a critical role of the insertion loop in the cytotoxic activity of TRAIL.

Articles - 1d2q mentioned but not cited (5)

  1. The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily. Won EY, Cha K, Byun JS, Kim DU, Shin S, Ahn B, Kim YH, Rice AJ, Walz T, Kwon BS, Cho HS. J Biol Chem 285 9202-9210 (2010)
  2. Structure of the Chlamydia trachomatis immunodominant antigen Pgp3. Galaleldeen A, Taylor AB, Chen D, Schuermann JP, Holloway SP, Hou S, Gong S, Zhong G, Hart PJ. J Biol Chem 288 22068-22079 (2013)
  3. Mechanistic basis for functional promiscuity in the TNF and TNF receptor superfamilies: structure of the LIGHT:DcR3 assembly. Liu W, Zhan C, Cheng H, Kumar PR, Bonanno JB, Nathenson SG, Almo SC. Structure 22 1252-1262 (2014)
  4. Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood. Mishra A, Dey S. Biomolecules 9 E740 (2019)
  5. Analysis of naproxen activation of cell death pathways in Colo320 cells. Chen A, Zhu W, Goding R. Mol Clin Oncol 21 61 (2024)


Reviews citing this publication (27)

  1. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Idriss HT, Naismith JH. Microsc Res Tech 50 184-195 (2000)
  2. New insights into apoptosis signaling by Apo2L/TRAIL. Gonzalvez F, Ashkenazi A. Oncogene 29 4752-4765 (2010)
  3. Onto better TRAILs for cancer treatment. de Miguel D, Lemke J, Anel A, Walczak H, Martinez-Lostao L. Cell Death Differ 23 733-747 (2016)
  4. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Eissner G, Kolch W, Scheurich P. Cytokine Growth Factor Rev 15 353-366 (2004)
  5. Structural principles of tumor necrosis factor superfamily signaling. Vanamee ÉS, Faustman DL. Sci Signal 11 eaao4910 (2018)
  6. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Holoch PA, Griffith TS. Eur J Pharmacol 625 63-72 (2009)
  7. Principles of antibody-mediated TNF receptor activation. Wajant H. Cell Death Differ 22 1727-1741 (2015)
  8. Molecular mechanisms of death-receptor-mediated apoptosis. Sartorius U, Schmitz I, Krammer PH. Chembiochem 2 20-29 (2001)
  9. TRAILing death in cancer. Mellier G, Huang S, Shenoy K, Pervaiz S. Mol Aspects Med 31 93-112 (2010)
  10. Regulation of the human TRAIL gene. Allen JE, El-Deiry WS. Cancer Biol Ther 13 1143-1151 (2012)
  11. TRAIL gene therapy: from preclinical development to clinical application. Griffith TS, Stokes B, Kucaba TA, Earel JK, VanOosten RL, Brincks EL, Norian LA. Curr Gene Ther 9 9-19 (2009)
  12. Role of pancreatic β-cell death and inflammation in diabetes. Quan W, Jo EK, Lee MS. Diabetes Obes Metab 15 Suppl 3 141-151 (2013)
  13. Tumor necrosis factor family ligand-receptor binding. Zhang G. Curr Opin Struct Biol 14 154-160 (2004)
  14. The TRAIL to viral pathogenesis: the good, the bad and the ugly. Cummins N, Badley A. Curr Mol Med 9 495-505 (2009)
  15. Resistance to TRAIL and how to surmount it. Maksimovic-Ivanic D, Stosic-Grujicic S, Nicoletti F, Mijatovic S. Immunol Res 52 157-168 (2012)
  16. The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder. Rosevear HM, Lightfoot AJ, O'Donnell MA, Griffith TS. Cancer Metastasis Rev 28 345-353 (2009)
  17. Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy. Naval J, de Miguel D, Gallego-Lleyda A, Anel A, Martinez-Lostao L. Cancers (Basel) 11 E444 (2019)
  18. Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries. Montinaro A, Walczak H. Cell Death Differ 30 237-249 (2023)
  19. Cell surface receptors. Deller MC, Yvonne Jones E. Curr Opin Struct Biol 10 213-219 (2000)
  20. Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy. Kretz AL, von Karstedt S, Hillenbrand A, Henne-Bruns D, Knippschild U, Trauzold A, Lemke J. Cancers (Basel) 10 E77 (2018)
  21. Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities. Martinez-Lostao L, de Miguel D, Al-Wasaby S, Gallego-Lleyda A, Anel A. Immunotherapy 7 883-882 (2015)
  22. Overview of protein structural and functional folds. Sun PD, Foster CE, Boyington JC. Curr Protoc Protein Sci Chapter 17 Unit 17.1 (2004)
  23. Death receptor ligands in tumors. Cappello P, Novelli F, Forni G, Giovarelli M. J Immunother 25 1-15 (2002)
  24. TNF superfamily protein-protein interactions: feasibility of small- molecule modulation. Song Y, Buchwald P. Curr Drug Targets 16 393-408 (2015)
  25. Functional roles in cell signaling of adaptor protein TRADD from a structural perspective. Li Z, Yuan W, Lin Z. Comput Struct Biotechnol J 18 2867-2876 (2020)
  26. The tumour necrosis factor receptor family: life or death choices. Jones EY. Curr Opin Struct Biol 10 644-648 (2000)
  27. TRAIL-Sensitizing Effects of Flavonoids in Cancer. Luiz-Ferreira A, Pacifico T, Cruz ÁC, Laudisi F, Monteleone G, Stolfi C. Int J Mol Sci 24 16596 (2023)

Articles citing this publication (61)



Quick links